SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-391738
Filing Date
2013-10-04
Accepted
2013-10-04 17:06:30
Documents
1
Group Members
SV LIFE SCIENCES ADVISERS, LLCSV LIFE SCIENCES FUND IV (GP), L.P.SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L.P.SV LIFE SCIENCES FUND IV, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d608253dsc13d.htm SC 13D 145737
  Complete submission text file 0001193125-13-391738.txt   147418
Mailing Address 5 VAUGHN DRIVE SUITE 106 PRINCETON NJ 08540
Business Address 5 VAUGHN DRIVE SUITE 106 PRINCETON NJ 08540 609-945-6050
Ophthotech Corp. (Subject) CIK: 0001410939 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87636 | Film No.: 131137363
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108
Business Address ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108 617-367-8100
SVLSF IV, LLC (Filed by) CIK: 0001422339 (see all company filings)

IRS No.: 000000000
Type: SC 13D